US Stock MarketDetailed Quotes

VTGN VistaGen Therapeutics

Watchlist
  • 3.1000
  • -0.0500-1.59%
Close Nov 6 16:00 ET
  • 3.0800
  • -0.0200-0.65%
Post 20:01 ET
83.87MMarket Cap-3333P/E (TTM)

VistaGen Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

VistaGen Therapeutics Q2 2025 Estimates Date

Currency：USDNov 7, 2024

Estimate YoY
Revenue
33.33K
-88.00%
EPS
-0.39
+40.92%
Analyst Rating
Buy

Aug 15, 2024

VistaGen Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q3 -- / 33.330K --
Nov 7, 2024 2025/Q2 -- / 33.330K --
Aug 13, 2024 2025/Q1 84.000K / 298.500K --
Jun 11, 2024 2024/Q4 197.300K / 202.750K --
Feb 13, 2024 2024/Q3 411.400K / 544.500K --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 33.330K--
Nov 7, 20242025/Q2-- / 33.330K--
Aug 13, 20242025/Q184.000K / 298.500K--
Jun 11, 20242024/Q4197.300K / 202.750K--
Feb 13, 20242024/Q3411.400K / 544.500K--

Unlock Free Earnings Estimates

VistaGen Therapeutics Earnings Reports

  • VistaGen Therapeutics | 10-Q: Q1 2025 Earnings Report

    Aug 14 04:52

  • VistaGen Therapeutics | 10-K: FY2024 Annual Report

    Jun 12 04:29

  • VistaGen Therapeutics | 10-Q: Q3 2024 Earnings Report

    Feb 14 05:31

  • VistaGen Therapeutics | 10-Q: Q2 2024 Earnings Report

    Nov 10, 2023 05:44

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 15, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data